Application of clinical pathway in cyclocryotherapy in treatment of refractory glaucoma

Abstract

AIM: To analyze the implementation value of clinical path in cyclocryotherapy for refractory glaucoma. METHODS: Refractory glaucoma patients who underwent cyclocryotherapy treatment in the ophthalmology department from January 2011 to December 2011 were included, 24 eyes of 23 cases were treated with the clinical path, and 20 eyes of 20 cases as control group. An average length of stay, preoperative average length of stay, average cost of hospitalization, the cure rate, and patient satisfaction indicators were compared between two groups RESULTS: There was no difference in the effective rate of surgery between two groups(83% vs 80%). The average length of stay and average hospital costs were less in path group than the control group(4.2d vs 8.3d, 2138 vs 2 787), but patient satisfaction was higher than the control group(96% vs 85%), and the difference was statistically significant(P <0.05). CONCLUSION: The clinical pathway in the ciliary body frozen for refractory glaucoma contribute to standardize the surgical procedure to ensure that the operation is successful and improve work efficiency and the quality of medical services.

Keywords

• ciliary body frozen
• refractory glaucoma
• clinical pathway
• quality
• efficiency
• management